Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | OGA | O60502 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 7/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6840373 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL27924535 | 0.78 | OGA (0.45) | NOS1SMN1; SMN2OGATRPV1HSD11B1 | |
| SCHEMBL12791651 | 0.76 | OGA (0.44) | NOS1SMN1; SMN2OGAHSD11B1RAB9A | |
| SCHEMBL14212540 | 0.75 | HSD11B1 (0.37) | NOS1SMN1; SMN2OGACNR2TRPV1 | |
| SCHEMBL10217223 | 0.74 | SSTR4 (0.39) | NOS1SMN1; SMN2OGATRPV1HSD11B1 | |
| SCHEMBL5291304 | 0.74 | RAB9A (0.46) | NOS1SMN1; SMN2OGAHSD11B1RAB9A | |
| SCHEMBL24676000 | 0.74 | OGA (0.40) | NOS1SMN1; SMN2OGATRPV1HSD11B1 | |
| SCHEMBL26384520 | 0.74 | SCN10A (0.36) | NOS1SMN1; SMN2CNR2TRPV1RAB9A | |
| SCHEMBL24676730 | 0.73 | SMN1; SMN2 (0.38) | NOS1SMN1; SMN2OGATRPV1HSD11B1 | |
| SCHEMBL21314668 | 0.73 | TRPV1 (0.39) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |